EcoDrugPlus

Mtor Associated Protein, Lst8 Homolog (S. Cerevisiae)

Ensembl ID : ENSEEEG00000009112
Gene Symbol: MLST8
4 Cross references
195 Possible Orthologues:

N-Acetylated Alpha-Linked Acidic Dipeptidase 2

Ensembl ID : ENSEEEG00000001437
Gene Symbol: NAALAD2
4 Cross references
340 Possible Orthologues:

Nadph Oxidase 4

Ensembl ID : ENSEEEG00000001384
Gene Symbol: NOX4
4 Cross references
150 Possible Orthologues:

Npc1 Like Intracellular Cholesterol Transporter 1

Ensembl ID : ENSEEEG00000023422
Gene Symbol: NPC1L1
4 Cross references
190 Possible Orthologues:

Ptk6 Protein Tyrosine Kinase 6b

Ensembl ID : ENSEEEG00000006809
Gene Symbol: PTK6B
4 Cross references
160 Possible Orthologues:

Pim-1 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSEEEG00000022420
Gene Symbol: PIM1
4 Cross references
250 Possible Orthologues:

Pim-3 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSEEEG00000017164
Gene Symbol: PIM3
4 Cross references
178 Possible Orthologues:

Pim-3 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSEEEG00000021498
Gene Symbol: PIM3
4 Cross references
164 Possible Orthologues:

Raf-1 Proto-Oncogene, Serine/threonine Kinase A

Ensembl ID : ENSEEEG00000009503
Gene Symbol: RAF1A
4 Cross references
207 Possible Orthologues:

Raf-1 Proto-Oncogene, Serine/threonine Kinase B

Ensembl ID : ENSEEEG00000008185
Gene Symbol: RAF1B
4 Cross references
156 Possible Orthologues:

Rho-Associated, Coiled-Coil Containing Protein Kinase 1

Ensembl ID : ENSEEEG00000010204
Gene Symbol: ROCK1
2 Cross references
212 Possible Orthologues:

Sem1 26s Proteasome Subunit

Ensembl ID : ENSEEEG00000022013
Gene Symbol: SEM1
4 Cross references
156 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).